Efficacy of Tenofovir-Based Combination Therapy versus Tenofovir Monotherapy in Chronic Hepatitis B Patients Presenting with Suboptimal Responses to Pretreatment: A Meta-Analysis

<div>Forest map of summary estimates for comparison of the changes in HBeAg between TDF-based combination therapy and monotherapy groups. (a) HBeAg loss; (b) HBeAg seroconversion.</div>

Gastroenterology Research and Practice

fig3

Figure 3

Figure 3: Efficacy of Tenofovir-Based Combination Therapy versus Tenofovir Monotherapy in Chronic Hepatitis B Patients Presenting with Suboptimal Responses to Pretreatment: A Meta-Analysis 

Figure 3 | Efficacy of Tenofovir-Based Combination Therapy versus Tenofovir Monotherapy in Chronic Hepatitis B Patients Presenting with Suboptimal Responses to Pretreatment: A Meta-Analysis 